Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: Daiichi Sankyo
Condition: Breast Cancer
NCT03248492
A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: large_enrollment_target_signal
Stopped reason
Context when available
The last participant was transitioned to alternative study.